EpiPen Agreement Protects Medicaid Integrity, Saves Hundreds of Millions of Dollars
EpiPen Agreement Protects Medicaid Integrity, Saves Hundreds of Millions of Dollars The Centers for Medicare & Medicaid Services (CMS) is pleased to announce an agreement with Mylan regarding the classification of EpiPen. Per the agreement, Mylan will reclassify EpiPen as a brand name drug consistent with the Medicaid statute and regulations. In addition, Mylan has agreed to use the Continue reading EpiPen Agreement Protects Medicaid Integrity, Saves Hundreds of Millions of Dollars
You must be logged in to post a comment.